Table 1.

Immune defects in chronic lymphocytic leukemia (CLL).

Primary 
  • B-cell defects

    • Hypogammaglobulinemia

    • Poor response to vaccination

  • T-cell defects

    • Quantitative: increased numbers

    • Qualitative

      • Skewed repertoire, decreased CD4/8 ratio

      • Th 2 polarization

      • Abnormal CD30 response

      • Reversible acquired CD40L deficiency

      • Gene expression abnormalities (cytoskeleton, granules)

  • NK cell

    • lack of granules

    • reduced killing activity

  • Neutrophils

    • reduced phagocytic and bactericidal function

    • abnormal migration and chemotaxis

  • Monocytes/macrophages

    • reduced cytotoxcity

  • Complement

    • reduction in levels and defects in activation and binding

 
Secondary 
  • Bone marrow failure due to advanced disease

  • Toxicity (myeloid and lymphoid) due to therapy

 
Primary 
  • B-cell defects

    • Hypogammaglobulinemia

    • Poor response to vaccination

  • T-cell defects

    • Quantitative: increased numbers

    • Qualitative

      • Skewed repertoire, decreased CD4/8 ratio

      • Th 2 polarization

      • Abnormal CD30 response

      • Reversible acquired CD40L deficiency

      • Gene expression abnormalities (cytoskeleton, granules)

  • NK cell

    • lack of granules

    • reduced killing activity

  • Neutrophils

    • reduced phagocytic and bactericidal function

    • abnormal migration and chemotaxis

  • Monocytes/macrophages

    • reduced cytotoxcity

  • Complement

    • reduction in levels and defects in activation and binding

 
Secondary 
  • Bone marrow failure due to advanced disease

  • Toxicity (myeloid and lymphoid) due to therapy

 
Close Modal

or Create an Account

Close Modal
Close Modal